Literature DB >> 12522333

Interference of dapsone in HbA1c monitoring of a diabetic patient with polychondritis.

J Serratrice1, B Granel, L Swiader, P Disdier, C De Roux-Serratrice, D Raccah, P J Weiller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12522333

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN： 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  5 in total

1.  Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions.

Authors:  Kerry J Welsh; M Sue Kirkman; David B Sacks
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

2.  Falsely Decreased HbA1c in a Type 2 Diabetic Patient Treated with Dapsone.

Authors:  Arti D Shah; Rena K Fox; Robert J Rushakoff
Journal:  Endocr Pract       Date:  2014-11       Impact factor: 3.443

3.  Unexpectedly low HbA1c levels in two diabetes patients following dapsone use.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Ramamurthy Jayashri; Viswanathan Mohan
Journal:  Indian J Endocrinol Metab       Date:  2012-07

4.  Drugs affecting HbA1c levels.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Indian J Endocrinol Metab       Date:  2012-07

5.  Artifactually lowered glycosylated hemoglobin (HbA1c %) in patient with diabetes on dapsone.

Authors:  Amit Rastogi; Ankur Gahlot; N K Agrawal; S K Singh
Journal:  Indian J Endocrinol Metab       Date:  2012-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.